RS62517B1 - Derivati imidazopiridina i njihova upotreba kao leka - Google Patents

Derivati imidazopiridina i njihova upotreba kao leka

Info

Publication number
RS62517B1
RS62517B1 RS20211347A RSP20211347A RS62517B1 RS 62517 B1 RS62517 B1 RS 62517B1 RS 20211347 A RS20211347 A RS 20211347A RS P20211347 A RSP20211347 A RS P20211347A RS 62517 B1 RS62517 B1 RS 62517B1
Authority
RS
Serbia
Prior art keywords
medicament
imidazopyridine derivatives
imidazopyridine
derivatives
Prior art date
Application number
RS20211347A
Other languages
English (en)
Inventor
Riccardo Giovannini
Angelo Ceci
Georg Dahmann
Cornelia Dorner-Ciossek
Lothar Kussmaul
Roland Pfau
Dieter Wiedenmayer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of RS62517B1 publication Critical patent/RS62517B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
RS20211347A 2017-12-08 2018-12-06 Derivati imidazopiridina i njihova upotreba kao leka RS62517B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17206152 2017-12-08
EP18826510.2A EP3720855B1 (en) 2017-12-08 2018-12-06 Imidazopyridine derivatives and the use thereof as medicament
PCT/EP2018/083728 WO2019110703A1 (en) 2017-12-08 2018-12-06 Imidazopyridine derivatives and the use thereof as medicament

Publications (1)

Publication Number Publication Date
RS62517B1 true RS62517B1 (sr) 2021-11-30

Family

ID=60629568

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20211347A RS62517B1 (sr) 2017-12-08 2018-12-06 Derivati imidazopiridina i njihova upotreba kao leka

Country Status (31)

Country Link
US (1) US10849907B2 (sr)
EP (1) EP3720855B1 (sr)
JP (1) JP6941235B2 (sr)
KR (1) KR20200097301A (sr)
CN (1) CN111344291B (sr)
AR (1) AR113923A1 (sr)
AU (1) AU2018379438B2 (sr)
BR (1) BR112020008583A2 (sr)
CA (1) CA3083331A1 (sr)
CL (1) CL2020001402A1 (sr)
CO (1) CO2020006648A2 (sr)
CY (1) CY1124744T1 (sr)
DK (1) DK3720855T3 (sr)
EA (1) EA202091139A1 (sr)
ES (1) ES2897050T3 (sr)
HR (1) HRP20211726T1 (sr)
HU (1) HUE056667T2 (sr)
IL (1) IL274868B1 (sr)
LT (1) LT3720855T (sr)
MA (1) MA51020B1 (sr)
MX (1) MX2020005869A (sr)
PE (1) PE20211454A1 (sr)
PL (1) PL3720855T3 (sr)
PT (1) PT3720855T (sr)
RS (1) RS62517B1 (sr)
SA (1) SA520412155B1 (sr)
SG (1) SG11202005138TA (sr)
SI (1) SI3720855T1 (sr)
TW (1) TWI809014B (sr)
UA (1) UA126247C2 (sr)
WO (1) WO2019110703A1 (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020245137A1 (en) * 2019-06-04 2020-12-10 Boehringer Ingelheim International Gmbh Imidazopyrazine derivatives and the use thereof as medicament
WO2020245136A1 (en) * 2019-06-04 2020-12-10 Boehringer Ingelheim International Gmbh Purine derivatives, as nr2b negative modulators and the use thereof as medicament, in particular for treating depressive disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495561B2 (en) * 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
MXPA04000737A (es) 2001-07-24 2004-07-08 Richter Gedeon Vegyeszet Derivados de piperidina como antagonistas receptores de nmda.
WO2010088414A2 (en) 2009-01-28 2010-08-05 Emory University Subunit selective nmda receptor potentiators for the treatment of neurological conditions
EP2909180B1 (en) 2012-10-18 2016-10-05 F. Hoffmann-La Roche AG Ethynyl derivatives as modulators of mglur5 receptor activity
CA2936886A1 (en) 2014-02-27 2015-08-03 Merck Patent Gmbh Heterocyclic compounds as nav channel inhibitors and uses thereof
WO2015187845A1 (en) * 2014-06-04 2015-12-10 Rugen Holdings (Cayman) Limited Difluoroethylpyridine derivatives as nr2b nmda receptor antagonists
WO2016029146A1 (en) * 2014-08-22 2016-02-25 University Of Washington Specific inhibitors of methionyl-trna synthetase
CA2957898C (en) * 2014-09-15 2023-02-21 Rugen Holdings (Cayman) Limited Pyrrolopyrimidine derivatives as nr2b nmda receptor antagonists

Also Published As

Publication number Publication date
JP6941235B2 (ja) 2021-09-29
ES2897050T3 (es) 2022-02-28
US10849907B2 (en) 2020-12-01
UA126247C2 (uk) 2022-09-07
SI3720855T1 (sl) 2021-12-31
SA520412155B1 (ar) 2022-06-05
CA3083331A1 (en) 2019-06-13
HUE056667T2 (hu) 2022-02-28
DK3720855T3 (da) 2021-11-08
WO2019110703A1 (en) 2019-06-13
AR113923A1 (es) 2020-07-01
PL3720855T3 (pl) 2022-01-24
HRP20211726T1 (hr) 2022-02-18
CL2020001402A1 (es) 2020-09-21
BR112020008583A2 (pt) 2020-10-20
MX2020005869A (es) 2020-09-09
SG11202005138TA (en) 2020-06-29
AU2018379438B2 (en) 2022-08-18
MA51020B1 (fr) 2021-10-29
LT3720855T (lt) 2021-11-10
CN111344291A (zh) 2020-06-26
EP3720855A1 (en) 2020-10-14
IL274868A (en) 2020-07-30
JP2021505584A (ja) 2021-02-18
TWI809014B (zh) 2023-07-21
CO2020006648A2 (es) 2020-06-09
US20190175605A1 (en) 2019-06-13
KR20200097301A (ko) 2020-08-18
AU2018379438A1 (en) 2020-05-07
EP3720855B1 (en) 2021-08-25
CY1124744T1 (el) 2022-07-22
TW201936198A (zh) 2019-09-16
EA202091139A1 (ru) 2020-11-23
IL274868B1 (en) 2024-02-01
PT3720855T (pt) 2021-11-03
PE20211454A1 (es) 2021-08-05
CN111344291B (zh) 2023-05-05
MA51020A (fr) 2021-05-26

Similar Documents

Publication Publication Date Title
IL246757B (en) New insulin histories and their medical uses
IL257173A (en) New insulin histories and their medical uses
PT3421038T (pt) Compostos de naftiridina, combinações médicas e sua utilização
GB201617064D0 (en) Compounds and their therapeutic use
GB201715194D0 (en) Compounds and their therapeutic use
IL282527A (en) 5-Azaindazole history and their use
IL274868A (en) History of imidazopyridine and their use as medicine
IL282526A (en) 5-Azaindazole history and their use
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
IL282142A (en) The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine
ZA201607353B (en) Bicyclic derivatives and pharmaceutical composition including the same
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
EP3227293A4 (en) 6.7-cyclicmorphinan derivatives and use thereof
PL3250181T3 (pl) Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw
EP3192513A4 (en) 7-fluoro-8-chloro-5 -dibenzo[b,e][1,4]diazepine derivatives and use thereof
HK1251558A1 (zh) 新的酰亞胺衍生物及其作為藥物的用途
HRP20182167T1 (hr) Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba
PL3606534T3 (pl) Pochodne fosfolipidów i ich zastosowanie jako leki